Asian Spectator


The Times

.

LANDMARK’s ‘Destination CENTRAL’ Opens an Inspiring New Chapter for the Festive Season in Hong Kong

Heightening the Global Momentum of Louis Vuitton’s Monumental Façade and Welcoming the Arrival of “Christmas at The Gloucester Hotel”HONG KONG SAR – Media OutReach News...

Audrey Hepburn's Son Sean Hepburn Ferrer Vindicated By Court D...

LOS ANGELES, Dec. 3, 2019 /PRNewswire-AsiaNet/ -- Audrey Hepburn's eldest son, Sean Hepburn Ferrer, prevailed in a lawsuit brought against him by a charitable organization he established in ...

ONYX Hospitality Group Named Best Local Hotel Brand – Thailand at the 34th Annual TTG Travel Awards 2025

BANGKOK, THAILAND - Media OutReach Newswire - 26 September 2025 - ONYX Hospitality Group, a leading hotel management company in Southeast Asia with a diverse portfolio of hotels, resorts, s...

KERUI Petroleum Wins the Largest UPGN Project in Brazil

BEIJING, April 9, 2018 /PRNewswire-AsiaNet/ -- In the past few days, the SPE led by Shandong KERUI Petroleum Equipment Limited (hereinafter referred to as "KERUI Petroleum") has successfully...

TUMI Highlights Peruvian Influences with Vibrant Energy in Spring 2025 Collections

HONG KONG SAR - Media OutReach Newswire – 5 February 2025 - TUMI, the leading international travel, lifestyle and accessories brand, is ushering in Spring 2025 with vibrant energy. Th...

PR Newswire's APAC Media Landscape 2022 Report Shares Top Indu...

HONG KONG, June 23, 2022 /PRNewswire-AsiaNet/ -- PR Newswire, the leading global provider of news distribution and earned media software and services, launched its APAC Media Landscape 2022 ...

Chinese Liquor Maker Moutai Establishes International Scholars...

SYDNEY, June 2, 2018 /PRNewswire-AsiaNet/-- The program is Moutai's first effort in the field of educational grantsOn May 31, the University of New South Wales (UNSW), world-renowned for its...

EPFR Sets Sights on Major Investment Program as Independent Bu...

BOSTON, Oct. 3, 2022 /PRNewswire-AsiaNet/ -- - The preeminent financial data provider has partnered with leading private equity firm Montagu to fast-track expansion of data assets, analytic ...

StartmeupHK Festival 2023 offers opportunity for diving into Hong Kong’s influential startup community over a week-long extravaganza of innovation

A fantastic opportunity to meet global business leaders and explore Hong Kong’s booming startup scene across the city HONG KONG SAR - Media OutReach - 10 October 2023 - The annual St...

SinoMab Granted the Most Popular Newly Listed Company Award

HONG KONG, Jan 10, 2020 - (ACN Newswire) - SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group"; stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, is pleased to announce that the Group has won the title of the "Most Popular Newly Listed Company" at the 4th Hong Kong Golden Stocks Awards held in Shenzhen.

image

The 4th Hong Kong Golden Stocks Awards was jointly organized by Zhitongcaijing.com, China's leading information platform focusing on Hong Kong and US stock markets, and 10jka.com.cn. The "Most Popular Newly Listed Company" award aims at recognizing companies had been listed on Hong Kong Stock Exchange since 1 January 2019 with significant recognition from the industry, high participation of investors and excellent performance in capital markets. Being awarded the "Most Popular Newly Listed Company" demonstrates the industry and investors' close attention towards biotech industry and is a great encouragement and motivation for SinoMab's future success. SinoMab, as the first Hong Kong-listed local biopharmaceutical company, possesses several first-in-target and first-in-class drug candidates. As the drug candidate coming the closest to commercialization, the Company's flagship product SM03 is currently in Phase III clinical trial for RA in China and is expected to be marketed in 2021 the soonest. According to the latest statistics, approximately 300 patients have taken the treatment trial. Meanwhile, the Company has proactively carried out long-term development plan. Its Suzhou production base is expected to be put into operation by the end of 2021 to satisfy the commercialized production requirements of drug candidates in the future.

After three months of strict screening, the 4th Hong Kong Golden Stocks Awards attracted over 860 Hong Kong-listed companies to participate, covering emerging industries such as TMT and healthcare. The award is a recognition of SinoMab's R&D strengths, business model and industry influence from the market and investors and will help improving the Company's reputation in the capital market.

About SinoMab BioScience Limited SinoMab BioScience Limited ("SinoMab" or the "Company", stock code: 3681.HK) is dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases. The Company's flagship product SM03 is a potential global first-in-target mAb against CD22 for the treatment of rheumatoid arthritis and is currently in Phase III clinical trial for rheumatoid arthritis in China, which has been recognized as one of the significant special projects of Significant New Drugs Development of the Twelfth Five-Year Plan Period and the Thirteenth Five-Year Plan Period. In addition, the Company possesses other potential first-in-target and first-in-class drug candidates, some of which are already in clinical stage, with their indications covering rheumatoid arthritis, systemic lupus erythematosus, non-Hodgkin's lymphoma, asthma, and other diseases with major unmet clinical needs.

Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

What to Consider Before Choosing a Cardboard Box Manufacturer

Start With the Packaging Purpose The right packaging begins with a clear understanding of what the box needs to do. A cardboard box manufacturer can help translate requirements such as product prot...

Why Emotional Battles Drain Your Wealth During Separation

Navigating a marriage ending is fundamentally a structural transition, not just an emotional event. When you approach separation with a clear roadmap, you protect your long term financial stability ...

How Long Does Botox Really Last? A Realistic Timeline

Someone might notice a line between their eyebrows getting deeper after a stressful week, or catch their forehead creasing in a video call in a way it did not before. It is a small observation, easy...

hacklink esim senegalzlibraryzlibraryuk casinos not on gamstophttps://www.capitolcitycinema.org/grandpashabet girişStreamEastCrackStreamsjojobetcialis 20 mg fiyathttps://elektroniksigarakeyfi.net/marka/voopoo/